0000939767-16-000288.txt : 20161207
0000939767-16-000288.hdr.sgml : 20161207
20161207190349
ACCESSION NUMBER: 0000939767-16-000288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161205
FILED AS OF DATE: 20161207
DATE AS OF CHANGE: 20161207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCANGOS GEORGE A
CENTRAL INDEX KEY: 0001202102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 162040152
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
4
1
wf-form4_148115541665566.xml
FORM 4
X0306
4
2016-12-05
0
0000939767
EXELIXIS, INC.
EXEL
0001202102
SCANGOS GEORGE A
C/O EXELIXIS, INC.
210 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2016-12-05
4
M
0
357976
8.99
A
1668186
D
Common Stock
2016-12-05
4
S
0
204718
17.81
D
1463468
D
Common Stock
2016-12-07
4
M
0
356
8.99
A
1463824
D
Common Stock
2016-12-07
4
S
0
176
17.90
D
1463648
D
Common Stock
8963
I
By Trust (JS)
Common Stock
8963
I
By Trust (KS)
Common Stock
5669
I
By 401(k) Plan
Option (right to buy)
8.99
2016-12-05
4
M
0
357976
0
D
2007-12-08
2016-12-07
Common Stock
357976.0
356
D
Option (right to buy)
8.99
2016-12-07
4
M
0
356
0
D
2007-12-08
2016-12-07
Common Stock
356.0
0
D
Includes 1,596 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.45 to $18.00. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
Represents 5,669 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 2, 2016.
The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to 100,000 shares on December 8, 2007, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the original grant date (December 8, 2006). The option ceased vesting on July 15, 2010, in connection with the Reporting Person's resignation as President and Chief Executive Officer of Exelixis, Inc., at which time the option was exercisable as to as to 358,332 shares of Exelixis, Inc. Common Stock.
/s/ Jeffrey J. Hessekiel, Attorney in Fact
2016-12-07